Mustang Bio to Present at 8th Annual Partnering Forum at Cell & Gene Meeting on the Mesa Oct 01, 2018
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-101 Sep 25, 2018
Fortress Biotech Announces Publication of Preclinical Data on AAV-ATP7A Gene Therapy Combined with CUTX-101 (Copper Histidinate) for Menkes Disease in Molecular Therapy: Methods & Clinical Development Sep 12, 2018
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101 Sep 06, 2018
Mustang Bio Announces Presentations on CAR T Therapies at 4th Annual CAR-TCR Summit 2018 Sep 04, 2018
Checkpoint Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference Aug 30, 2018
